Clinical Trial Update: Multiple Rising Dose Study of BI 144807 Powder in Bottle in Mild Asthmatic Patients [Phase 1]

View source ↗

Summary

Boehringer Ingelheim completed a Phase 1 multiple rising-dose study of BI 144807 in mild asthmatic participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• BI 144807

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Healthy, Asthma | Phase 1 | Status: COMPLETED